Loring Wolcott & Coolidge Fiduciary Advisors’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Loring Wolcott & Coolidge Fiduciary Advisors's ABMD Position: Q4 2022 in Review
Loring Wolcott & Coolidge Fiduciary Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 15,692 shares — an estimated $3.85M sold.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in ABMD in Q3 2017 and held it in 21 quarters. The position peaked at $5.92M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 15,692 Abiomed Inc shares in Q4 2022, an estimated $3.85M.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Abiomed Inc in Q3 2017 and held it in 21 quarters.
- Loring Wolcott & Coolidge Fiduciary Advisors's Abiomed Inc position peaked at $5.92M in Q4 2021.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.